Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.76
-0.1200-1.35%
Post-market: 8.800.0400+0.46%17:36 EDT
Volume:2.42M
Turnover:21.15M
Market Cap:1.83B
PE:-33.76
High:8.87
Open:8.87
Low:8.69
Close:8.88
Loading ...

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and BioCryst (BCRX)

TIPRANKS
·
03 Mar

Is BioCryst Pharmaceuticals, Inc. (BCRX) the Best Small-Cap Stock to Buy Now?

Insider Monkey
·
01 Mar

BioCryst (BCRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
27 Feb

Here's Why BioCryst (BCRX) Could be Great Choice for a Bottom Fisher

Zacks
·
26 Feb

Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its Yearly Results

Simply Wall St.
·
26 Feb

Evercore ISI Sticks to Their Buy Rating for BioCryst (BCRX)

TIPRANKS
·
26 Feb

BioCryst Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Feb

RBC Capital Adjusts Price Target on BioCryst Pharmaceuticals to $11 From $10, Keeps Outperform Rating

MT Newswires Live
·
25 Feb

BioCryst Pharmaceuticals Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $15

THOMSON REUTERS
·
25 Feb

BioCryst selloff yesterday brings buying opportunity, says JPMorgan

TIPRANKS
·
25 Feb

BioCryst Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
25 Feb

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioCryst (BCRX), Addus Homecare (ADUS) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
25 Feb

Q4 2024 BioCryst Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
25 Feb

BioCryst Pharmaceuticals Inc (BCRX) Q4 2024 Earnings Call Highlights: Strong ORLADEYO Revenue ...

GuruFocus.com
·
25 Feb

BioCryst Pharmaceuticals (BCRX) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
25 Feb

BioCryst Pharmaceuticals Unveils Latest Trial Data, Reports Mixed Q4 Earnings

Benzinga
·
25 Feb

BioCryst Pharmaceuticals Shares Drop After Wider-Than-Expected 4Q Loss

Dow Jones
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

Reuters
·
24 Feb

BUZZ-BioCryst falls on wider-than-expected quarterly loss

Reuters
·
24 Feb

Stock Track | BioCryst Pharmaceuticals Plummets 7% on Q4 Earnings Miss, Raises 2025 Revenue Outlook

Stock Track
·
24 Feb